Zebra Analytix Awarded $1.8M Phase II Grant from National Institutes of Health

Fayetteville, AR — Zebra Analytix, a leading innovator in environmental monitoring solutions, is proud to announce that it has been awarded a Phase II grant from the Department of Health and Human Services National...

VIC Fellows Spotlight: Gopesh Tilvawala, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

Navigating Investment Opportunities in Medical Devices: A Guide for Savvy Investors

In the ever-evolving healthcare landscape, technological innovations continue to drive significant advancements. In this article, we delve into the realm of medical device investment, exploring key trends,...

Calyxo Announces FDA Clearance for Second Generation CVAC System

New Solution for Kidney Stone Treatment Already Used to Treat More than 50 Patients PLEASANTON, CA — Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, announced that...

The Ivory Tower’s Secret Mission: Academic to Commercial Translation

Universities and national laboratories inarguably serve a vital function in society. They are most widely known for their educational mission and service to learning and research. However, these institutions are also...

William McCoy, PhD, Joins Zebra Analytix's Board of Directors

Fayetteville, AR - Zebra Analytix, a pioneering company in miniaturization of advanced analytical instruments, is pleased to announce the appointment of William (Bill) McCoy, PhD, to its Board of Directors. Dr. McCoy is...

VIC 2023 Annual Report: Executive Summary

2023 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Fellows Spotlight: Jonathan Rayner, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

Solenic Medical to Exhibit at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco

Solenic Medical Inc. will be a first time exhibitor (Booth #4142) at The American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting February 12-14th. This is the premier event in the field of orthopaedic surgery,...

A Letter from our CEO

In the past year, we saw great achievements across our portfolio of high-impact life science companies despite a challenging overall fundraising environment. Our VIC Tech team and the portfolio company teams showed...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
News
Solenic Medical, Inc. Announces $5.1M Series A Funding Round Led by Johnson & Johnson Innovation – JJDC, Inc.
Interview
VIC Fellows Spotlight: Matthew Leming, PhD
From The Corner Office
From the Corner Office: Michael Artinger, PhD – CEO of Solaris Vaccines, Inc.